Article
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approach.
HIV medicine - 1 Oct 2007
Yazdanpanah Y, Vray M, Meynard J, Losina E, Weinstein M C, Morand-Joubert L, Goldie S J, Hsu H E, Walensky R P, Dalban C, Sax P E, Girard P M, Freedberg K A
Abstract excerpt
OBJECTIVES: Resistance testing in HIV disease may provide long-term benefits that are not evident from short-term data. Our objectives were to estimate the long-term effectiveness, cost and cost-effectiveness of genotype testing in patients with extensive antiretroviral exposure. METHODS: We used an HIV simulation model to estimate the long-term effectiveness and cost-effectiveness of genotype testing. Clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.